Notification of Major Interest in Mediclinic International plc shares Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 (“Mediclinic”, the “Company” or the “Group”) 29 January 2019 Notification of Major Interest in Mediclinic International plc shares 1a. Identity of the issuer or the underlying issuer Mediclinic International plc. of existing shares to which voting rights are at- tached: 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for the notification (please mark the appropriate box or boxes with an “X”) An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments An event changing the breakdown of voting rights Other (please specify)iii: 3. Details of person subject to the notification obligation Name Coronation Asset Management (Pty) Ltd acting as dis- cretionary investment manager on behalf of managed portfolios. City and country of registered office (if applicable) Cape Town, South Africa 4. Full name of shareholder(s) (if different from 3.)v Name N/A City and country of registered office (if applicable) 5. Date on which the threshold was crossed or 29/01/2019 reached: 6. Date on which issuer notified (DD/MM/YYYY): 29/01/2019 7. Total positions of person(s) subject to the notification obligation % of voting rights at- % of voting rights Total of both in % Total number of tached to shares (to- through financial instru- (8.A + 8.B) voting rights of is- tal of 8. A) ments suer (total of 8.B 1 + 8.B 2) Resulting situation 2.82 2.82 737 243 810 on the date on which threshold was crossed or reached Position of previous 3.98 3.98 notification (if applicable) 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached A: Voting rights attached to shares Class/type of Number of voting rights % of voting rights shares ISIN code (if possible) Direct Indirect Direct Indirect (Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive 2004/109/EC) (DTR5.1) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC) (DTR5.2.1) (DTR5.2.1) GB00B8HX8Z88 20 825 908 2.82 SUBTOTAL 8. A 20 825 908 2.82 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) Type of financial in- Expiration Exercise/ Number of voting rights % of voting rights strument date Conversion Period that may be acquired if the instrument is exercised/converted. SUBTOTAL 8. B 1 B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) Type of financial Expiration Exercise/ Physical or Number of % of voting rights instrument date Conversion Pe- cash voting rights riod settlement SUBTOTAL 8.B.2 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”) Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity xiv X (please add additional rows as necessary) Name % of voting rights % of voting rights Total of both if it if it equals or is through financial equals or is higher higher than the instruments if it than the notifiable notifiable thresh- equals or is higher threshold old than the notifiable threshold Coronation Fund Managers Ltd Coronation Investment Management SA (Pty) Ltd Coronation Asset Management (Pty) Ltd 2.82 2.82 10. In case of proxy voting, please identify: Name of the proxy holder The number and % of voting rights held The date until which the voting rights will be held 11. Additional information Place of completion Cape Town, South Africa Date of completion 29/01/2019 Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia. For further information, please contact: Company Secretary, Link Company Matters Limited Jayne Meacham / Caroline Emmet +44 (0)20 7954 9569 Investor Relations, Mediclinic International plc James Arnold, Head of Investor Relations ir@mediclinic.com +44 (0)20 3786 8181 Media queries FTI Consulting Brett Pollard/Debbie Scott – UK +44 (0)20 3727 1000 Sherryn Schooling – South Africa +27 (0)21 487 9000 Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom Website: www.mediclinic.com Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Ltd Date: 29/01/2019 04:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.